VWM
DGX icon

Vermillion Wealth Management’s Quest Diagnostics DGX Stock Holding History

Vermillion Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7
Closed -$1.37K – 1780
2026
Q1 		$1.37K Buy
+7
New +$1.36K ﹤0.01% 748

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Vermillion Wealth Management's DGX Position: Q2 2026 in Review

Vermillion Wealth Management sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 7 shares — an estimated $1.37K sold.

Vermillion Wealth Management first reported a position in DGX in Q1 2026 and held it in 1 quarter. The position peaked at $1.37K in Q1 2026. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Vermillion Wealth Management reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
  • Vermillion Wealth Management sold 7 Quest Diagnostics shares in Q2 2026, an estimated $1.37K.
  • Vermillion Wealth Management first reported a position in Quest Diagnostics in Q1 2026 and held it in 1 quarter.
  • Vermillion Wealth Management's Quest Diagnostics position peaked at $1.37K in Q1 2026.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.